y 27632 has been researched along with n(6)-cyclopentyladenosine in 1 studies
| Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (n(6)-cyclopentyladenosine) | Trials (n(6)-cyclopentyladenosine) | Recent Studies (post-2010) (n(6)-cyclopentyladenosine) |
|---|---|---|---|---|---|
| 1,924 | 3 | 891 | 605 | 0 | 62 |
| Protein | Taxonomy | y 27632 (IC50) | n(6)-cyclopentyladenosine (IC50) |
|---|---|---|---|
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.2256 | |
| Adenosine receptor A2b | Rattus norvegicus (Norway rat) | 1.16 | |
| Adenosine receptor A1 | Homo sapiens (human) | 0.0027 | |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | 1.16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assaloni, R; Bartoli, E; Cavarape, A; Endlich, K; Endlich, N; Parekh, N; Steinhausen, M | 1 |
1 other study(ies) available for y 27632 and n(6)-cyclopentyladenosine
| Article | Year |
|---|---|
Rho-kinase inhibition blunts renal vasoconstriction induced by distinct signaling pathways in vivo.
Topics: Adenosine; Amides; Animals; Endothelins; Enzyme Inhibitors; Female; Guanylate Cyclase; Indoles; Intracellular Signaling Peptides and Proteins; Oxadiazoles; Peptide Fragments; Protein Kinase C; Protein Serine-Threonine Kinases; Purinergic P1 Receptor Agonists; Pyridines; Quinoxalines; Rats; Rats, Wistar; Receptor, Endothelin B; Receptors, Endothelin; Renal Circulation; rho-Associated Kinases; Signal Transduction; Vasoconstriction; Vasomotor System | 2003 |